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In malaria-endemic areas, Plasmodium falciparum parasitemia is common in apparently healthy children and
severe malaria is commonly misdiagnosed in patients with incidental parasitemia. We assessed whether the plas-
ma Plasmodium falciparumDNA concentration is a useful datum for distinguishing uncomplicated from severe
malaria in African children and Asian adults. P. falciparum DNA concentrations were measured by real-time
polymerase chain reaction (PCR) in 224 African children (111 with uncomplicated malaria and 113 with severe
malaria) and 211 Asian adults (100 with uncomplicated malaria and 111 with severe malaria) presenting with
acute falciparum malaria. The diagnostic accuracy of plasma P. falciparum DNA concentrations in identifying
severe malaria was 0.834 for children and 0.788 for adults, similar to that of plasma P. falciparum HRP2 levels
and substantially superior to that of parasite densities (P < .0001). The diagnostic accuracy of plasma P. falcip-
arum DNA concentrations plus plasma P. falciparum HRP2 concentrations was signiﬁcantly greater than that
of plasma P. falciparum HRP2 concentrations alone (0.904 for children [P = .004] and 0.847 for adults
[P = .003]). Quantitative real-time PCR measurement of parasite DNA in plasma is a useful method for diag-
nosing severe falciparum malaria on fresh or archived plasma samples.
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Severe falciparum malaria is a major cause of childhood
death in sub-Saharan Africa, where it is a common di-
agnosis in severely ill children. In areas of moderate and
high transmission, malaria parasitemia is also common
in apparently healthy children. Because of this, the spe-
ciﬁcity of a blood slide for malaria is poor, and malaria
is consequently overdiagnosed. Postmortem studies in-
dicate that nearly 25% of children dying with a clinical
diagnosis of cerebral malaria actually died from other
causes [1], resulting in the underdiagnosis of other
treatable severe infections. Improving the speciﬁcity of
the diagnosis of severe malaria is therefore a priority.
Recent studies showed that careful ophthalmoscopy to
detect the retinopathy speciﬁc to cerebral malaria [2]
and quantitation of plasma concentrations of Plasmodi-
um falciparum HRP2 as a measure of parasite biomass
[3] separately improved diagnostic accuracy substan-
tially in severe falciparum malaria.
Because P. falciparum HRP2 is released at the time of
schizont rupture, we investigated the hypothesis that
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plasma concentrations of DNA (reﬂecting liberated merozoites
and degraded parasites) might also reﬂect the cumulative para-
site burden and, thus, the severity of disease in falciparum ma-
laria. Plasma concentrations of bacterial DNA have been shown
to correlate with severity in a number of invasive bacterial infec-
tions [4–6]. Several studies have documented the presence of P.
falciparum DNA in plasma or serum [7–9] but have not exam-
ined the relationship between plasma P. falciparum DNA con-
centrations and malaria severity. We reasoned that DNA
released into the plasma by schizont rupture or degradation
of sequestered parasites might be a better measure of the previ-
ously sequestered biomass and, thus, disease severity than pe-
ripheral parasitemia. We assessed the diagnostic performance
of plasma P. falciparum DNA concentration, alone and then
combined with plasma P. falciparum HRP2 concentration and
parasitemia, to distinguish between uncomplicated and strictly
deﬁned severe malaria in African children and Asian adults.
METHODS
Cases
The pediatric study involved children with symptomatic P.
falciparum malaria in East Africa. Samples from uncompli-
cated cases were obtained during longitudinal community
studies undertaken between February and August 2008 in
Handeni district, northeast Tanzania. These were febrile chil-
dren with a positive result of a rapid diagnostic test (RDT) for
P. falciparum lactate dehydrogenase (pLDH) but no clinical
signs or laboratory indicators of severe malaria [10]. Samples
from severe cases came from children with a positive result of
a pLDH RDT and signs of severe malaria consecutively re-
cruited in the Teule (northeast Tanzania) and Beira (central
Mozambique) centers of a large multinational randomized
controlled trial (AQUAMAT) that compared quinine and ar-
tesunate for the treatment of severe malaria [11]. Plasma
DNA concentrations were determined for sets of consecutive
samples obtained in Handeni during 2008, in Teule during
2007, and Beira during 2009. The adult study involved sam-
ples from all nonpregnant adults (≥16 years old) who were
admitted to the hospital with slide- or RDT-conﬁrmed falcip-
arum malaria and enrolled in prospective studies at Chitta-
gong Medical College Hospital, Bangladesh (2009–2011),
and Ispat General Hospital, Rourkela, India (2011). Uncom-
plicated and severe cases were deﬁned using modiﬁed World
Health Organization criteria [12] and all were treated with ar-
tesunate either parenterally [11] or orally as part of artemisi-
nin-combination therapy.
Ethics approval was granted by the Oxford Tropical Research
and London School of Hygiene and Tropical Medicine ethics
committees and relevant local ethical committees. Written in-
formed consent was obtained from all patients or an attending
relative.
Measurements
Parasitemia was calculated for children with uncomplicated ma-
laria, using the thick ﬁlm parasite count per 200 leukocytes and
the actual WBC count; if the WBC count was missing, the par-
asite count was calculated by assuming a WBC count of 8000
leukocytes/μL (count/200 leukocytes × 40) [10]. In the AQUA-
MAT study of severely ill children and the adult studies in
Bangladesh and India, parasitemia was calculated from the
thin blood ﬁlm by examining 1000 red blood cells (count/1000
erythrocytes × 125.6 × hematocrit).
Baseline plasma specimens were collected in tubes containing
ethylenediaminetetraacetic acid and stored at −80°C until test-
ing. The method for measuring plasma P. falciparum HRP2
concentrations and resulting levels in the pediatric study have
been described previously [3, 10].
Plasma P. falciparum DNA Quantitation
To measure the parasite DNA concentration in each plasma
sample, absolute quantitative real-time polymerase chain reac-
tion (qPCR) analysis was performed directly by using plasma
(2 μL) as a template without any DNA extraction step, 18S ribo-
somal RNA–targeting primers, and hydrolysis probes [13]. A
Corbett Rotor-Gene-6000 cycler (Corbett Life Science, Sydney,
Australia) was used with Quanti-Tect Multiplex PCR NoROX
(Qiagen, Hilden, Germany) reaction mix. The PCR reaction
mixture was prepared by using Quanti-Tect Buffer, 0.4 µM of
each primer, and 0.2 µM of hydrolysis probe. The reaction con-
ditions involved initial denaturation for 15 minutes at 95°C, 50
cycles of denaturation for 15 seconds at 94°C, and annealing for
60 seconds at 60°C.
A calibration standard was prepared using a highly synchro-
nized culture of the 3D7 P. falciparum line. Suspensions con-
taining precisely 10 000 ring-stage-infected red blood cells per
tube were obtained using ﬂuorescence-activated cell sorting,
as described by Malleret et al [14]. The standard curves were lin-
ear (r2 > 0.98), with ampliﬁcation efﬁciencies of 90%–105%. No
nonspeciﬁc ampliﬁcation products were seen on gel electropho-
resis and by sequencing qPCR products from a range of ﬁeld
samples (Macrogen, Seoul, Korea). To check cross-contamina-
tion of samples during qPCR processing, negative controls
(water) were added randomly (8 negative controls per 48 sam-
ples). Precision was assessed by 5 independent measurements
of 5 samples spanning the range of DNA concentrations encoun-
tered (1.7 up to 37 000 genome equivalents/µL), with coefﬁcients
of variation ranging from 0.67% to 1.98% (cycle threshold),
equivalent to 13.8%–38.2% (parasite genomes/µL).
Statistics
Statistical comparisons between groups were performed using
theMann–Whitney test. Area under the receiver operating char-
acteristic curve (AUROC) analyses for parasitemia, plasma con-
centrations of P. falciparum HRP2, and plasma concentrations
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of P. falciparum DNA were evaluated in Stata v 12.0 (Statacorp,
USA), using logistic regression to calculate AUROC values for
pairs of explanatory variables.
RESULTS
Samples were obtained from 435 patients, comprising 224 chil-
dren in Tanzania and Mozambique (111 with uncomplicated
malaria and with 113 severe malaria, of whom 17 died) and
211 adults in Bangladesh and India (100 with uncomplicated
malaria and 111 with severe malaria, of whom 33 died). Base-
line characteristics of the 2 groups are shown in Table 1.
Plasma P. falciparum DNA and P. falciparum HRP2 concen-
trations and peripheral parasitemia for the respective groups of
patients are shown in Figure 1. Plasma P. falciparumDNA levels
were approximately 40-fold and 10-fold higher in cases of se-
vere malaria, compared with those in cases of uncomplicated
malaria, in African children (median level, 98.7 genomes/µL
in the severe group vs 2.22 genomes/µL in the uncomplicated
group; P < .0001) and Asian adults (median level, 78.9 ge-
nomes/µL in the severe group vs 8.18genomes/µL in the un-
complicated group; P < .0001), respectively.
The AUROC values (Figure 2) for severe malaria were 0.834
and 0.789 for children and adults, respectively (Table 2). Anal-
ogous values for plasma P. falciparum HRP2 levels were 0.857
and 0.818, respectively. Both methods of assessment were
substantially more accurate than parasitemia in differentiating
severe from uncomplicated malaria (0.599 and 0.643, respective-
ly; P < .0001 for both comparisons in both adults and children).
There was no signiﬁcant difference in AUROC values between
plasma P. falciparum DNA concentrations and P. falciparum
HRP2 concentrations (P = .43 and P = .29 for children and
adults, respectively). Use of plasma P. falciparum DNA concen-
trations plus plasma P. falciparumHRP2 concentrations led to a
further improvement in diagnostic accuracy, compared with use
of P. falciparum HRP2 concentrations alone (for children, the
AUROC increased to 0.904 [P = .004]; for adults, the AUROC
increased to 0.847 [P = .003]). By comparison, use of parasite-
mia plus plasma P. falciparum HRP2 concentrations did not
signiﬁcantly improve the AUROC in either children (P = .5)
or adults (P = .7).
P. falciparum DNA concentrations in plasma specimens ob-
tained at admission were not signiﬁcantly associated with mor-
tality within the severe malaria groups (for children, the median
DNA level was 126 genomes/µL in survivors vs 94 genomes/μL
in those who died [P = .96]; for adults, the median DNA level
was 74.6 genomes/µL in survivors vs 96.3 in those who died
[P = .42]). Parasitemia similarly did not predict outcome within
the severe group in either location, whereas the plasma P. falcip-
arum HRP2 level predicted outcome in Asian adults (median,
1741 ng/mL in survivors vs 3021 ng/mL in those who died;
P = .009) but not in African children (median, 1535 ng/mL in
survivors vs 3992 ng/mL in those who died [P = .148]).
DISCUSSION
The presence of species-speciﬁc Plasmodium DNA in patients’
plasma or serum has been recognized since the introduction of
PCR methods for malaria diagnosis and genotyping [7, 8]. This
nucleic acid derives presumably from degraded intraerythro-
cytic parasites and free merozoites. During the expansion
phase of malaria, multiplication can exceed 50% efﬁciency
Table 1. Baseline Characteristics of African Children and Asian Adults With Plasmodium falciparum Malaria, by Malaria Severity
Characteristic
Children Adults
Uncomplicated
(n = 111)
Severe
(n = 113)
Uncomplicated
(n = 100)
Severe
(n = 111)
Age, y 3.0 (1.9–4.2) 3.1 (1.5–4.9) 25 (20–40) 30 (22–42)
Female sex 50 (45) 57 (50) 28 (28) 32 (29)
Temperature, °Ca 38.5 ± 1.0 38.2 ± 0.9 37.8 ± 1.1 38.3 ± 1.2
Hemoglobin concentration, g/dL 9.8 (9.0–11.1) 6.5 (4.6–8.4) 10.5 (7.9–12.8) 9.7 (7.0–11.5)
Microscopy positive for P. falciparum 103 (96)b 105 (99)c 97 (99)d 111 (100)
Parasitemia, parasites/µL 44 080 (17 720–81 120) 63 868 (14 789–201 965) 14 821 (2606–67 039) 40 186 (11 681–223 128)
Plasma P. falciparum HRP2
concentration, ng/mL
204 (95–435) 1690 (665–4271) 311 (123–763) 1973 (734–4263)
Plasma P. falciparum DNA
concentration, genomes/µL
2.2 (0.6–12.2) 98.7 (13.0–635.3) 8.2 (0.8–36.2) 78.9 (25.7–1083)
Died 0 (0) 17 (15) 0 (0) 33 (30)
Data are no. (%) of patients, mean ± SD, or median (interquartile range).
a Axillary in children, tympanic membrane in adults.
b Data missing for 4 children.
c Data missing for 7 children.
d Data missing for 2 adults.
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(calculated as the parasite multiplication rate/average number
of merozoites per schizont), but this rate falls abruptly at high
densities, which must therefore generate a large number of free
merozoites that are cleared by phagocytic cells. The relative
contributions of merozoites and degraded intraerythrocytic
parasites in producing the plasma P. falciparum DNA concen-
tration are not known but could be tested by centrifugation or
ﬁltering to remove different sizes of particulate matter that con-
tain parasite DNA. The kinetics of the production and elimina-
tion of plasma parasite DNA have not yet been characterized;
studies of human DNA circulation in plasma indicate that
rapid hepatic clearance occurs [15]. The half-life of fetal DNA
in plasma is approximately 15 minutes [16].
Plasma concentrations of P. falciparum DNA reﬂected dis-
ease severity in falciparum malaria. Plasma P. falciparum
DNA levels performed considerably better in both Asian adults
and African children than peripheral parasitemia as a mea-
sure of disease severity and performed similarly to the recently
validated plasma P. falciparumHRP2 as a severity measure [10].
The well-recognized poor performance of the peripheral blood
parasite count as a severity measure is because the circulat-
ing parasites in falciparum malaria are not those causing the
pathological processes; rather, the more mature sequestered
parasites obstruct the microvasculature of vital organs. The
number of these hidden pathological parasites is better reﬂected
in the extraerythrocytic parasite products that circulate in
plasma.
Importantly, the combination of plasma P. falciparum HRP2
and P. falciparum DNA concentrations was signiﬁcantly more
accurate than either measure alone. Additivity in accuracy of
Figure 1. Parasitemia (A), plasma Plasmodium falciparum HRP2 concentration (B), and plasma P. falciparum DNA concentration (C) among African chil-
dren and Asian adults who had uncomplicated malaria, who survived severe malaria, and who died from severe malaria.
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diagnostic performance suggests that the 2 markers provide
independent measures of severity. This may reﬂect differing in-
trinsic mechanisms and kinetics of production and elimination.
It might also result from covariates affecting either marker that
are independent of parasite biomass, so that the 2 measures
complement each other. Potential covariates include P. falcipa-
rum HRP2 gene deletion [17] (although our previous survey
based on plasma P. falciparum HRP2 levels in African children
found no evidence of this [18]), differential P. falciparum HRP2
expression [19], and small copy number variations in the rDNA
units containing the 18S (SSU) sequences used to detect para-
site DNA [20, 21]. Despite its strong association with severity,
the plasma parasite DNA level did not predict mortality in
either group of patients. The reasons are unclear; possible expla-
nations include a temporal dissociation between microvascular
obstruction and DNA release or a stronger association between
high DNA concentrations and less severe syndromes of severe
malaria.
A clinical deﬁnition of severe malaria was used as the gold
standard for calculations of diagnostic accuracy (measured as
the AUROC). However, in the AQUAMAT study (in which
the severe pediatric cases were studied), one third of cases (de-
ﬁned by the ranking of plasma P. falciparum HRP2 concentra-
tions) had no mortality beneﬁt from artesunate, compared with
quinine, which suggests that they may have had another lethal
disease (most likely invasive bacterial infections) [3]. This sug-
gests that the gold standard for comparative evaluation is im-
perfect and that, in children with clinically diagnosed severe
malaria, there is a theoretical maximum diagnostic accuracy,
as speciﬁcity is diluted by cases in which malaria is not actually
the cause of severe illness. Accuracy in clinical trials would
improve with stricter deﬁnitions involving conﬁrmation of ma-
larial retinopathy, but this applies only to cerebral malaria,
which usually composes less than half of the cases presenting
with severe malaria, and so would lack sensitivity [22]. In
low-transmission settings where adults develop severe malaria,
coincidental peripheral blood parasitemia is less frequent;
therefore, among ill adults, parasitemia has good speciﬁcity
for malaria, although parasite density is still relatively inaccurate
as a severity measure. The smaller differences in plasma P. fal-
ciparum DNA concentrations between the uncomplicated and
Figure 2. Receiver operating characteristic curves for test discrimination of uncomplicated from severe malaria in African children (A) and Asian adults
(B ) with Plasmodium falciparum malaria.
Table 2. Area Under the Receiver Operating Characteristic Curve
(AUROC) Values for Measures of Malaria Severity Among African
Children and Asian Adults With Plasmodium falciparum Malaria
Measure
Children Adults
AUROC P Valuea AUROC P Valuea
Parasitemia .599 .643
P. falciparum HRP2 level .857 .818
P. falciparum DNA level .834 .43 .789 .29
P. falciparum HRP2 and
DNA levels
.904 .004 .847 .003
P. falciparum HRP2
level + parasitemia
.867 .51 .826 .68
a Versus P. falciparum HRP2 level alone.
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severe cases among adults, compared with those observed
among children, in this study may be explained by disease se-
verity. The adults with uncomplicated malaria studied in Ban-
gladesh and India were sufﬁciently ill to warrant admission to a
referral hospital (ie, a small minority of cases overall), had high-
er plasma P. falciparum HRP2 and P. falciparum DNA concen-
trations, and probably had more-severe infections than the
African children with uncomplicated malaria recruited in the
community-based studies.
Quantitation of plasma P. falciparum DNA concentrations is
currently unlikely to be incorporated into prospective patient
management, although rapid advances in PCR technology
may change this. The P. falciparum DNA concentration is a
useful prognostic measure in research studies and may provide
valuable information from previous studies in which plasma or
serum samples have been archived. qPCR can be readily adapt-
ed to a high-throughput format. Plasma measurements reﬂect-
ing the sequestered parasite burden are valuable indicators of
disease severity in falciparum malaria.
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